Prostatype Genomics AB (OSTO:PROGEN) Short-Term Debt : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Short-Term Debt?

Prostatype Genomics AB's Short-Term Debt for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Prostatype Genomics AB's quarterly Short-Term Debt declined from Dec. 2023 (kr11.60 Mil) to Jun. 2024 (kr0.00 Mil) but then stayed the same from Jun. 2024 (kr0.00 Mil) to Dec. 2024 (kr0.00 Mil).

Prostatype Genomics AB's annual Short-Term Debt increased from Dec. 2022 (kr0.40 Mil) to Dec. 2023 (kr11.60 Mil) but then declined from Dec. 2023 (kr11.60 Mil) to Dec. 2024 (kr0.00 Mil).

Prostatype Genomics AB Short-Term Debt Historical Data

The historical data trend for Prostatype Genomics AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Short-Term Debt Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

0.40

11.60

Prostatype Genomics AB Semi-Annual Data
	Jun18	Jun19	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt	Get a 7-Day Free Trial						0.40	0.40	11.60	-	-

Prostatype Genomics AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Prostatype Genomics AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB Headlines

No Headlines